Corrigendum to "Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants" [J. Affect. Disord. 208 (2017, Jan. 15) 6-14, doi: 10.1016/j.jad.2016.08.029, Epub 2016 Oct. 1].
作者信息
Mischoulon D, Hylek L, Yeung A S, Clain A J, Baer L, Cusin C, Ionescu D F, Alpert J E, Soskin D P, Fava M
机构信息
Depression Clinical and Research Program, Department of Psychiatry, The Massachusetts General Hospital/Harvard Medical School, Boston, MA, United States.
Depression Clinical and Research Program, Department of Psychiatry, The Massachusetts General Hospital/Harvard Medical School, Boston, MA, United States.
出版信息
J Affect Disord. 2018 Feb;227:198. doi: 10.1016/j.jad.2017.10.040. Epub 2017 Nov 5.
PMID:29100152
Abstract
摘要
Zotero 插件